vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Hippo Holdings Inc. (HIPO). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $120.4M, roughly 2.0× Hippo Holdings Inc.). Hippo Holdings Inc. runs the higher net margin — 5.0% vs -35.0%, a 40.0% gap on every dollar of revenue. On growth, Hippo Holdings Inc. posted the faster year-over-year revenue change (18.2% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $9.1M). Over the past eight quarters, Hippo Holdings Inc.'s revenue compounded faster (18.9% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Hippo Valley Estate is a sugar estate found near the town of Chiredzi in Chiredzi District of southeastern Zimbabwe, on the Runde River near the border with Mozambique.

CCRN vs HIPO — Head-to-Head

Bigger by revenue
CCRN
CCRN
2.0× larger
CCRN
$236.8M
$120.4M
HIPO
Growing faster (revenue YoY)
HIPO
HIPO
+41.8% gap
HIPO
18.2%
-23.6%
CCRN
Higher net margin
HIPO
HIPO
40.0% more per $
HIPO
5.0%
-35.0%
CCRN
More free cash flow
CCRN
CCRN
$7.0M more FCF
CCRN
$16.1M
$9.1M
HIPO
Faster 2-yr revenue CAGR
HIPO
HIPO
Annualised
HIPO
18.9%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
HIPO
HIPO
Revenue
$236.8M
$120.4M
Net Profit
$-82.9M
$6.0M
Gross Margin
Operating Margin
-30.2%
5.6%
Net Margin
-35.0%
5.0%
Revenue YoY
-23.6%
18.2%
Net Profit YoY
-2109.7%
-86.4%
EPS (diluted)
$-2.56
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
HIPO
HIPO
Q4 25
$236.8M
$120.4M
Q3 25
$250.1M
$120.6M
Q2 25
$274.1M
$117.3M
Q1 25
$293.4M
$110.3M
Q4 24
$309.9M
$101.9M
Q3 24
$315.1M
$95.5M
Q2 24
$339.8M
$89.6M
Q1 24
$379.2M
$85.1M
Net Profit
CCRN
CCRN
HIPO
HIPO
Q4 25
$-82.9M
$6.0M
Q3 25
$-4.8M
$98.1M
Q2 25
$-6.7M
$1.3M
Q1 25
$-490.0K
$-47.7M
Q4 24
$-3.8M
$44.2M
Q3 24
$2.6M
$-8.5M
Q2 24
$-16.1M
$-40.5M
Q1 24
$2.7M
$-35.7M
Gross Margin
CCRN
CCRN
HIPO
HIPO
Q4 25
Q3 25
20.4%
Q2 25
20.4%
Q1 25
20.0%
Q4 24
Q3 24
20.4%
Q2 24
20.8%
Q1 24
20.4%
Operating Margin
CCRN
CCRN
HIPO
HIPO
Q4 25
-30.2%
5.6%
Q3 25
-2.4%
81.3%
Q2 25
-2.1%
3.4%
Q1 25
-0.3%
-41.3%
Q4 24
-1.1%
46.3%
Q3 24
0.9%
-5.4%
Q2 24
-5.7%
-40.7%
Q1 24
0.8%
-38.7%
Net Margin
CCRN
CCRN
HIPO
HIPO
Q4 25
-35.0%
5.0%
Q3 25
-1.9%
81.3%
Q2 25
-2.4%
1.1%
Q1 25
-0.2%
-43.2%
Q4 24
-1.2%
43.4%
Q3 24
0.8%
-8.9%
Q2 24
-4.7%
-45.2%
Q1 24
0.7%
-42.0%
EPS (diluted)
CCRN
CCRN
HIPO
HIPO
Q4 25
$-2.56
$0.31
Q3 25
$-0.15
$3.77
Q2 25
$-0.20
$0.05
Q1 25
$-0.02
$-1.91
Q4 24
$-0.13
$1.81
Q3 24
$0.08
$-0.34
Q2 24
$-0.47
$-1.64
Q1 24
$0.08
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
HIPO
HIPO
Cash + ST InvestmentsLiquidity on hand
$108.7M
$218.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$436.1M
Total Assets
$449.0M
$1.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
HIPO
HIPO
Q4 25
$108.7M
$218.3M
Q3 25
$99.1M
$247.7M
Q2 25
$81.2M
$198.9M
Q1 25
$80.7M
$140.9M
Q4 24
$81.6M
$197.6M
Q3 24
$64.0M
$191.2M
Q2 24
$69.6M
$175.9M
Q1 24
$5.2M
$223.4M
Stockholders' Equity
CCRN
CCRN
HIPO
HIPO
Q4 25
$322.8M
$436.1M
Q3 25
$408.1M
$421.5M
Q2 25
$412.2M
$332.5M
Q1 25
$418.2M
$322.8M
Q4 24
$419.0M
$362.1M
Q3 24
$424.7M
$326.4M
Q2 24
$433.3M
$322.6M
Q1 24
$462.4M
$351.2M
Total Assets
CCRN
CCRN
HIPO
HIPO
Q4 25
$449.0M
$1.9B
Q3 25
$538.2M
$1.9B
Q2 25
$553.8M
$1.7B
Q1 25
$576.2M
$1.5B
Q4 24
$589.3M
$1.5B
Q3 24
$597.4M
$1.5B
Q2 24
$602.9M
$1.5B
Q1 24
$648.4M
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
HIPO
HIPO
Operating Cash FlowLast quarter
$18.2M
$9.2M
Free Cash FlowOCF − Capex
$16.1M
$9.1M
FCF MarginFCF / Revenue
6.8%
7.6%
Capex IntensityCapex / Revenue
0.9%
0.1%
Cash ConversionOCF / Net Profit
1.53×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$14.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
HIPO
HIPO
Q4 25
$18.2M
$9.2M
Q3 25
$20.1M
$16.9M
Q2 25
$4.2M
$24.7M
Q1 25
$5.7M
$-35.6M
Q4 24
$24.2M
$47.5M
Q3 24
$7.5M
$46.8M
Q2 24
$82.4M
$-10.6M
Q1 24
$6.0M
$17.7M
Free Cash Flow
CCRN
CCRN
HIPO
HIPO
Q4 25
$16.1M
$9.1M
Q3 25
$17.9M
$16.8M
Q2 25
$2.3M
$24.6M
Q1 25
$3.8M
$-35.7M
Q4 24
$21.7M
$47.2M
Q3 24
$6.3M
Q2 24
$79.6M
$-10.7M
Q1 24
$3.8M
$17.6M
FCF Margin
CCRN
CCRN
HIPO
HIPO
Q4 25
6.8%
7.6%
Q3 25
7.2%
13.9%
Q2 25
0.8%
21.0%
Q1 25
1.3%
-32.4%
Q4 24
7.0%
46.3%
Q3 24
2.0%
Q2 24
23.4%
-11.9%
Q1 24
1.0%
20.7%
Capex Intensity
CCRN
CCRN
HIPO
HIPO
Q4 25
0.9%
0.1%
Q3 25
0.9%
0.1%
Q2 25
0.7%
0.1%
Q1 25
0.6%
0.1%
Q4 24
0.8%
0.3%
Q3 24
0.4%
0.0%
Q2 24
0.8%
0.1%
Q1 24
0.6%
0.1%
Cash Conversion
CCRN
CCRN
HIPO
HIPO
Q4 25
1.53×
Q3 25
0.17×
Q2 25
19.00×
Q1 25
Q4 24
1.07×
Q3 24
2.92×
Q2 24
Q1 24
2.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

HIPO
HIPO

Segment breakdown not available.

Related Comparisons